Drug intelligence / Profile preview

Qinpi decoction

Development stage: Preclinical
Lead developer: Shanghai University of Traditional Chinese Medicine
Administration: Ophthalmic

Overview

Qinpi decoction is a traditional Chinese medicine (TCM) formulation being investigated for its potential to improve ocular surface conditions, refractive errors, and dry eye symptoms in patients with myopia. It is administered via ultrasonic atomization directly to the ocular surface.

Other names: 秦皮汤

Beyond the preview

Go deeper on Qinpi decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qinpi decoction.

Explore the full profile